You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 3, February 9, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Conflict of Interest
 •Complementary and Alternative Medicine
 •Osteoarthritis
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin: Relevant Financial Interest?

Since this article does not have an abstract, we have provided the first 100 words of the full text and any section headings.

In their article, Richy et al1 declare "no relevant financial interest in this article." I note, however, that one of the key trials2 cited in their systematic review (reference 24) was by some of the same authors. The Lancet study was sponsored by Rotta Research Laboratorium, Milan, Italy, who markets their product as a medicinal agent in various European Union countries and may be seeking to market their product as a medicinal agent in the United Kingdom. Under these circumstances, it would seem appropriate for the authors to declare their connection with Rotta, at least in terms of previous funding.

Paresh Jobanputra, DM, FRCP(Edin)
Birmingham, England

1. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Arch Intern Med. 2003;163:1514-1522. FREE FULL TEXT
2. Reginster JY, Deroisy R, Rovati RC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251-256. FULL TEXT | ISI | PUBMED

Arch Intern Med. 2004;164:338-339.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin: Relevant Financial Interest?—Reply
Jean-Yves Reginster
Arch Intern Med. 2004;164(3):339.
EXTRACT | FULL TEXT  

Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis: A Comprehensive Meta-analysis
Florent Richy, Olivier Bruyere, Olivier Ethgen, Michel Cucherat, Yves Henrotin, and Jean-Yves Reginster
Arch Intern Med. 2003;163(13):1514-1522.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.